Polyfunctional cytomegalovirus-specific CD4+ and pp65 CD8+ T cells protect against high-level replication after liver transplantation
- PMID: 18853954
- DOI: 10.1111/j.1600-6143.2008.02425.x
Polyfunctional cytomegalovirus-specific CD4+ and pp65 CD8+ T cells protect against high-level replication after liver transplantation
Erratum in
- Am J Transplant. 2011 May;11(5):1107
Abstract
To determine whether polyfunctional CD4+ T-cell responses coupled with CD8+ T-cell responses against human cytomegalovirus (HCMV) are key to the control of HCMV replication we prospectively analyzed 29 liver transplant recipients for CD4+ T-cell responses against soluble HCMV antigen, pp65 and IE1 proteins, CD8+ T-cell responses against pp65 and IE1 proteins and a range of T helper (Th) 1 and Th2 cytokines. Eleven patients (38%) developed HCMV DNAemia at a median of 21 days post-liver transplantation (range 17-31 days). There was a significantly lower frequency and absolute number of total HCMV CD4+ T cells producing IFNgamma, IFNgamma+IL2 and IL2 and pp65-CD8+ T cells producing IFNgamma in patients with DNAemia. The quantities of Th1 and Th2 cytokines present during the first 20 days posttransplant were not predictive of DNAemia. Cut-off levels during the first 20 days posttransplant of 0.1% of lysate stimulated CD4+ T cells producing IL2, and pp65-CD8+ T cells producing IFNgamma above 0.4% had positive and negative predictive values for DNAemia of 54% and 100% and 50% and 92%, respectively. Measuring polyfunctional CD4+ T cells against HCMV early posttransplant may allow targeted intervention to minimize the occurrence and acute and long-term consequences of HCMV replication.
Similar articles
-
Ex vivo stimulation and expansion of both CD4(+) and CD8(+) T cells from peripheral blood mononuclear cells of human cytomegalovirus-seropositive blood donors by using a soluble recombinant chimeric protein, IE1-pp65.J Virol. 2001 Sep;75(17):7840-7. doi: 10.1128/jvi.75.17.7840-7847.2001. J Virol. 2001. PMID: 11483727 Free PMC article.
-
Kinetics of cytomegalovirus (CMV) pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells during episodes of viral DNAemia in allogeneic stem cell transplant recipients: potential implications for the management of active CMV infection.J Med Virol. 2010 Jul;82(7):1208-15. doi: 10.1002/jmv.21799. J Med Virol. 2010. PMID: 20513086
-
Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients.Bone Marrow Transplant. 2010 Mar;45(3):543-9. doi: 10.1038/bmt.2009.172. Epub 2009 Jul 20. Bone Marrow Transplant. 2010. PMID: 19617905
-
Functional patterns of cytomegalovirus (CMV) pp65 and immediate early-1-specific CD8(+) T cells that are associated with protection from and control of CMV DNAemia after allogeneic stem cell transplantation.Transpl Infect Dis. 2015 Jun;17(3):361-70. doi: 10.1111/tid.12391. Epub 2015 Jun 1. Transpl Infect Dis. 2015. PMID: 25850900
-
Expansion of human cytomegalovirus (HCMV) immediate-early 1-specific CD8+ T cells and control of HCMV replication after allogeneic stem cell transplantation.J Virol. 2008 Oct;82(20):10143-52. doi: 10.1128/JVI.00688-08. Epub 2008 Aug 6. J Virol. 2008. PMID: 18684826 Free PMC article.
Cited by
-
Utility of CMV-Specific Immune Monitoring for the Management of CMV in Solid Organ Transplant Recipients: A Clinical Update.Diagnostics (Basel). 2021 May 13;11(5):875. doi: 10.3390/diagnostics11050875. Diagnostics (Basel). 2021. PMID: 34068377 Free PMC article. Review.
-
Cytomegalovirus replication kinetics in solid organ transplant recipients managed by preemptive therapy.Am J Transplant. 2012 Sep;12(9):2457-64. doi: 10.1111/j.1600-6143.2012.04087.x. Epub 2012 May 17. Am J Transplant. 2012. PMID: 22594993 Free PMC article.
-
Clinical Experience with Immune Monitoring for Cytomegalovirus in Solid-Organ Transplant Recipients.Curr Infect Dis Rep. 2013 Sep 29. doi: 10.1007/s11908-013-0369-6. Online ahead of print. Curr Infect Dis Rep. 2013. PMID: 24078428
-
CD4 T cell responses in latent and chronic viral infections.Front Immunol. 2013 May 13;4:105. doi: 10.3389/fimmu.2013.00105. eCollection 2013. Front Immunol. 2013. PMID: 23717308 Free PMC article.
-
Effect of Preemptive Therapy vs Antiviral Prophylaxis on Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors: A Randomized Clinical Trial.JAMA. 2020 Apr 14;323(14):1378-1387. doi: 10.1001/jama.2020.3138. JAMA. 2020. PMID: 32286644 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials